C ongenital heart disease (CHD) occurs in 1% of live-born children, but it occurs in a much higher percentage of pregnancies resulting in spontaneous abortion or stillbirth. 1 The etiology of CHD is often unknown. The maternal/placental microenvironment from conception to 8 weeks' gestation strongly influences the development of fetal organs. Cardiac defects may be explained, in part, by abnormalities in the microenvironment of the fetus. There exist shared molecular pathways that affect both fetal development and the maternal environment; therefore, aberrations in these pathways may cause both CHD as well as placental abnormalities. Data are limited with respect to the relationship between CHD and placental abnormalities, partly because most women do not know that they are pregnant until after the abnormal placental/cardiac microenvironment has affected the gestation. 1 Development of the placenta and heart occurs at a similar time and uses several of the same genes and molecular pathways. [2] [3] [4] Early in human gestation, the fertilized embryo implants in the endometrial lining of the uterine wall. Successful implantation requires adequate maternal uterine perfusion and endogenous hormone preparation to promote initial embryonic survival, organ development, and growth for a term gestation. 2 The similarities in placental and cardiac developmental pathways support our hypothesis that congenital abnormalities in the heart would be associated with abnormalities in the placenta.
Placental abnormalities and placental weight are directly correlated with birth weight. The placenta-tobirth weight ratio has been associated with certain shortand long-term perinatal outcomes. 5 Placental cord insertion may affect normal placental blood flow, and abnormal insertion may affect the microenvironment of the fetus, leading to disturbances in nutrient delivery. Several studies have found an association between intrauterine growth restriction (IUGR) and CHD. 6, 7 These associations support our hypothesis that placental abnormalities may serve as tools for further identification of fetuses at risk for CHD.
Materials and Methods

Study Design
This case-control study was approved by the Johns Hopkins Medicine Institutional Review Board. Infants with a diagnosis of CHD who underwent cardiac surgery within 6 months of life at Johns Hopkins Hospital from 2000 to 2013 were included as cases; patients (n 5 1117) who met these inclusion criteria were identified from the Johns Hopkins cardiac surgery database. Clinical data were reviewed in the medical record of the mother and the neonate to identify and apply the following exclusion criteria, which have established confounding effects on placental development: maternal diabetes, maternal hypertension, maternal coagulopathy, maternal renal failure, alcohol, smoking, illicit drugs, and chromosomal abnormalities. Isolated patent ductus arteriosus and mild CHD such as small septal defects and mild valvar stenosis were excluded, as these defects are unlikely to cause a hemodynamic impact in utero on a developing placenta. After the exclusion criteria were applied, a total of 200 cases were selected and matched on a one-to-one basis to normal pregnancy controls according to gestational age at birth.
Pathologic Evaluation of Placentas and Clinical Data Collection
After the exclusion criteria were applied, clinical data were extracted from the eligible cases (n 5 200). Placental weights and cord insertions were recorded. Data collection included the neonate's birth weight and anatomic type of CHD (Table 1) . The placenta-to-birth weight ratio was defined as the ratio of placental weight to birth weight.
Placental reports of all cases were reviewed by a single pathologist (F.A.) with experience in the evaluation of placental abnormalities. All placentas were weighed with attached membranes and without knowledge of "drain time" in the operating room or delivery suite. Placental measurements were acquired from the pathology report. Placentas were evaluated per the current AIUM practice parameter for the performance of obstetric ultrasound examinations 8 : "The placental location, appearance, and relationship to the internal cervical os should be documented. The umbilical cord should be imaged Congenital heart disease is known to be very heterogeneous. Clinical study is aided by broad anatomic categories, as listed in the first column. The cases included in this analysis are listed in the second column, reflecting how each lesion was categorized for the purpose of analysis. When a particular case could fit into more than 1 category, the clinically relevant diagnosis dictated the category. For example, a case of left heart hypoplasia with a ventricular septal defect was categorized as "left heart disease" as opposed to "septal defect." A case of an unbalanced atrioventricular canal with a hypoplastic left ventricle was categorized as "left heart disease" as well because of single-ventricle management.
and the number of vessels in the cord documented. The placental cord insertion site should be documented when technically possible." Cord insertion was categorized as central, paracentral, eccentric, marginal, or velamentous (ie, membranous). Cord insertions that were not marginal (ie, inserted at the edge of the placental disk) but inserted 3 cm or less from the nearest disk margin were considered eccentric, and the remainder were considered paracentral or central. 9 For the purpose of this study, we defined central and paracentral cord insertion as "normal" and all other insertion types as "abnormal." Microscopic examinations were performed on all placentas in this study, although the slides were not reviewed as part of this particular investigation.
Control placentas were chosen from placentas submitted to the Johns Hopkins Hospital Surgical Pathology Department between 2000 and 2003. All reports from sequentially accessioned placentas were reviewed. Placentas were further reviewed and selected as controls on the basis of the same exclusion criteria used for the cases. In addition, controls with CHD were excluded. Cases of IUGR were extracted from our initial data after we applied the exclusion criteria. We used the diagnosis of small for gestational age in the medical record as a proxy for IUGR. 6 
Statistical Analysis
Neonates with CHD were matched on a one-to-one basis by gestational age to neonates without CHD. Conditional logistic regression models were used to examine the association between the cord insertion type and the presence of CHD. Linear mixed-effects regression models were also used to explore the relationship between different types of CHD and the placenta-to-birth weight ratio. All of the models accounted for the correlation among the matched patients. Patient characteristics, placenta-to-birth weight ratio, gestational age, cord insertion type, and CHD type were also compared between neonates with IUGR and those without growth restriction. For the comparisons between neonates with and without IUGR, the nonparametric Kruskal-Wallis equality-of-populations rank test was used for the continuous variables, and the Fisher exact test was used for the categorical variables. A multinomial logistic regression model was used to examine the association between the type of CHD and IUGR status. Statistical significance in this study is reported as P values and 95% confidence intervals (CIs). P < .05 was considered statistically significant. Data analyses were performed with Stata version 14.0 software (StataCorp, College Station, TX).
Results
The characteristics of CHD cases and controls are listed in Table 2 . We quantified the relative proportions of the types of CHD, types of cord insertions, and placenta-tobirth weight ratios in the cases and controls. Placental weight data were not available for 4 of 200 cases. The mean placenta-to-birth weight ratio was observed to be nearly identical in cases versus controls. Cord insertion in most controls was either central or paracentral. In neonates with CHD, most cord insertions were paracentral or eccentric. The most frequently observed types of CHD in our cases were right and left heart disease, each of which composed approximately one-third of the cases. The remainder possessed conotruncal defects, septal defects, venous abnormalities, and combined left and right heart disease.
Abnormal Cord Insertion Is Associated With CHD
Placental cord insertion can be divided into central, paracentral, eccentric, marginal, and velamentous types, with central and paracentral insertions representing the normal conditions (Figure 1 ). Cord insertion data were not available for 9 of 200 cases. Due to the elevated rate of abnormal cord insertion observed in patients with CHD compared to controls, a conditional logistic regression model was used to evaluate the likelihood that a particular insertion site was associated with comorbid CHD (Table 3) . Eccentric insertion and marginal insertion were significantly associated with CHD. Velamentous insertion was associated with CHD also, with a lesser degree of statistical significance.
Abnormal Cord Insertion Is Associated
With Specific Subtypes of CHD When the infants were clustered into 2 groups according to placental pathologic characteristics (normal or abnormal cord insertion), we found differences in the pattern of cardiac outcomes (Table 4) . Among infants with normal cord insertion, the most common cardiac outcome was no CHD, followed by right heart disease and left heart disease. Among infants with abnormal cord insertion, more than one-third had no diagnosis of CHD, followed by right heart disease, left heart disease, and conotruncal defects. To further characterize the cardiac defects that are associated with abnormal cord insertion, the relative risk of each CHD subtype in comparison to the controls was calculated by multinomial logistic regression ( Table 5 ). The defects most strongly associated with abnormal cord insertion were conotruncal defects, left heart disease, and right heart disease.
Placental Birth Weight Ratio Is Not Associated With CHD Next, we evaluated the relationship between the placenta-to-birth weight ratio and CHD. A linear regression was performed to compare the placenta-to-birth weight ratio based on CHD subtype, with "no CHD" as the referent group (Table 6 ). The placenta-to-birth weight ratio was not significantly different among the CHD subtypes.
Presence of CHD Is Associated With IUGR When the infants were clustered into 2 groups (affected or unaffected by IUGR), we found an association with CHD (Table 7) . Among the IUGR infants, the number of cases with CHD was significantly higher than the proportion of cases among the non-IUGR infants (odds ratio, 3.00; 95% CI, 1.41-6.39). Although the placentato-birth weight ratio alone was not strongly associated with CHD, when we specifically assessed the placentato-birth weight ratio and the IUGR status, the IUGR infants had a significantly higher mean placenta-to-birth weight ratio. We detected a significant difference in the distribution of CHD types between IUGR and non-IUGR infants. Most of the non-IUGR infants did not have any type of CHD; in contrast, IUGR infants were most likely to have right or left heart disease. According to a multinomial logistic regression model, infants with IUGR were more likely to have left heart disease (relative risk ratio, 3.26; P 5 .025), right heart disease (relative risk ratio, 4.24; P 5 .003), and venous abnormalities (relative risk ratio, 7.71; P 5 .003) as opposed to not having any heart disease. We did not detect a significant difference in gestational age or cord insertion between non-IUGR and IUGR infants.
Discussion
To our knowledge, this study is the largest cohort of infants with CHD for whom placental pathology was analyzed, and is the first to provide clinical justification for prenatal placental screening as a risk stratification tool to further evaluate fetal cardiac defects. Our findings indicate that abnormal cord insertion onto the placenta is associated with an increased rate of CHD compared to centrally or paracentrally attached cords. Cord insertion is routinely evaluated during anatomy screening sonography and has been associated with placental and umbilical cord anomalies. 10 The cardiac defects most strongly associated with abnormal cord insertion were conotruncal defects, left heart disease, and right heart disease. This association also indicates that pediatricians and pediatric cardiologists should have an increased suspicion of CHD in a neonate with a delivery history that is positive for a non-centrally attached placental cord.
On the basis of prior observations that low placental weight is directly correlated with IUGR, we expected to find that the placenta-to-birth weight ratio was associated with CHD. Contrary to our expectations, we did not find that the placenta-to-birth weight could predict patients affected by CHD unless we restricted our analysis to those infants who were also affected by IUGR. Chronic placental insufficiency, which can be thought of as a functional problem with the placenta in contrast to the anatomic problem of abnormal cord insertion, could be present in some types of CHD. Chronic placental insufficiency could result in lower birth weight but not low enough to cause a statistically significantly low placenta-to-birth weight ratio, which would limit the utility of the analysis performed. Different types of CHD could have a distinct relationship with placental weight, depending on whether the underlying mechanism for the association is through a direct or indirect mechanism. Genetic studies in the mouse targeting the placenta indicate that at least 1 class of heart defects may be due to indirect effects secondary to placental insufficiency. 11, 12 However, the common vasculogenic programs in the heart and placenta certainly provide a rational reason for a direct causal connection for some cases. 7, 13 In particular, the canonical Wnt/b-catenin signaling pathway and the folate metabolism pathway are important during both placental and heart development and are part of what is called the "heart-placental axis." If these pathways are altered, developmental abnormalities may occur. For example, first-trimester pregnancy loss is a common occurrence and is often due to lethal congenital anomalies, including complex CHD. 1 Therefore, failure to maintain the pregnancy may be due to abnormal placental function, abnormal cardiac development, or both.
Given the simultaneous development of the heart and placenta during embryogenesis, it is likely that abnormal cardiac development leading to CHD is associated with abnormal placental development; evidence from basic science research supports this hypothesis. 2 In mice, targeted inactivation of the p38a/mitogen activated protein kinase gene leads to lethal cardiac defects that appear to be secondary to placental abnormalities. 14 A massive reduction of myocardial cells was detected in p38a 2/2 mutant mice as compared to controls, but no significant differences were found in cardiomyocyte proliferation or apoptosis. However, researchers detected significant abnormalities in placental morphologic characteristics: in particular, a lack of maternal-fetal vascularization in the labyrinthine layer. Thus, the lack of myocardial cells may have been due to an insufficient 18 (7) 20 (14) 38 ( Statistical analysis was performed by using multinomial logistic regression. Relative risk for cases of combined left and right heart disease is not reported because of the small sample size. morulae, the cardiac defects were also resolved, and embryos developed normally. 14 These results indicate that both cardiac and vascular development are strongly influenced by placental development. Further studies are warranted to better understand the critical heartplacental axis.
The diversity of mechanisms within the heartplacental axis may obscure relationships between particular heart defects and placental development. We performed a subgroup analysis to explore the possibility that placental abnormalities are confined to particular CHD subtypes. After including only the cases of patients affected with individual cardiac defects, we were unable to detect a statistically significant difference in the placenta-to-birth weight ratio among subtypes. Additionally, we did not identify a bias toward the types of CHD anomalies associated with IUGR.
Although IUGR was associated with an increased rate of CHD and an elevated placenta-to-birth weight ratio, there was no association with cord insertion. In our analysis of the placenta-to-birth weight ratio and CHD, there was no statistically significant difference Statistical analysis was performed by using linear mixed-effects regression models. Estimate for cases and controls of combined left and right heart disease is not reported because of the small sample size. in the placenta-to-birth weight ratio in the patients with CHD compared to the patients without CHD. A global evaluation of DNA methylation and other epigenetic modifications may reveal a similarity between IUGR and placental defects due to excess paternal imprinting. In cases of uniparental disomy of paternal origin, a bias toward excess paternal imprinting leads to overgrowth of the placenta at the expense of fetal development. In contrast, excess maternal imprinting would allow fetal developmental at the expense of placental development. This study was limited by several factors. The retrospective nature limits the study conclusions to associations and not causality. The recommendations regarding prenatal sonography are based on postnatal placental findings, and it is not certain that these findings do not change over gestation. The use of postnatal placental abnormalities is subject to clinical variability in the analysis. The placenta-to-birth weight ratio is an easy metric for fetal growth but has 2 main limitations. First, this ratio may not be the ideal way to identify placental abnormalities because there may be factors other than placental size that influence placental function critical for the developing embryo. Second, there is no systematic method for draining the blood from the placenta, so the placental weight measurement is highly dependent on hospital practices and methods.
In conclusion, this study is one of the only reviews of clinical placental abnormalities in association with CHD and provides additional data for fetal cardiac screening practices. Our findings indicate that cord insertion is abnormal in placentas of neonates with CHD. Therefore, abnormal cord insertion should raise concern for fetal CHD and prompt referral for fetal echocardiography. Future studies are needed to compare cord insertion at 20 weeks and at birth and to correlate cord insertion at 20 weeks by sonography with the presence of CHD. 15 Another noteworthy finding is that most of the cardiac defects in this study involved abnormalities of the cardiac outflow tracts, most of which have normal 4-chamber views and can therefore be missed when obstetric sonographic screening is limited to the 4-chamber view. 16 These data support the importance of incorporating fetal cardiac outflow tract views in fetal cardiac screening, as stated across multiple studies. 17, 18 Additional prospective studies, including histopathologic analysis of the placenta, are warranted to explore the associations between CHD, placental abnormalities, and growth. 
